HPV TEST + GARDASIL®
Protect Yourself From The Effects Of The Human Papilloma Virus (HPV)
The Human Papilloma Virus (HPV) is one of the most common sexually transmitted infections (STI) in Canada and around the world. Women between 15 and 29 are particularly susceptible to HPV. Approximately 90% of genital warts and 70% of cervical cancers worldwide are attributed to The Human Papilloma Virus. For women over 30 whose Pap test results show certain specific abnormalities, an HPV test is strongly recommended.
Located in Downtown Montreal, Les Cours Medical Centre’s GARDASIL® is the one vaccine will help prevent women from the devastating results of contact with 4 types of the Human Papilloma Virus (HPV), as long as the woman is vaccinated before any contact. GARDASIL® has also been shown to help protect against vulvar and vaginal cancers, as well as abnormal and precancerous cervical cells (as found in abnormal Pap tests) in women.
Research has shown that almost 75% of Canadian women will suffer from an HPV infection at one point in their lives – staggering numbers! Most concerning is the fact that the majority of people who become infected with HPV are not even aware of their condition, as many people with HPV will have no obvious signs of infection.
Results from our tests are available in an extremely expedient manner. Early detection is the key to identifying cancerous/pre-cancerous cells and will greatly improve your options in order to maintain your health. When it comes to your well-being, don’t wait.
Description of technology
HPV vaccine is given as a 3-dose series
- 1st Dose – Now
- 2nd Dose – 1 to 2 months after Dose 1
- 3rd Dose – 6 months after Dose 1
Additional (booster) doses are not recommended
The HPV vaccine you are getting is one of two vaccines that can be given to prevent HPV.
This vaccine can prevent most cases of cervical cancer in females, if it is given before exposure to the virus. In addition, it can prevent vaginal and vulvar cancer in females, and genital warts and anal cancer in both males and females.
Protection from HPV vaccine is expected to be long-lasting. But vaccination is not a substitute for cervical cancer screening. Women should still get regular Pap tests.